Patents by Inventor Hans Ulrich Schorlemmer

Hans Ulrich Schorlemmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies with specificity for membrane-associated antigens
    Patent number: 6294172
    Abstract: Monoclonal antibodies with specificity for membrane-associated antigens and methods of using them in detection of tumor-associated antigens arc described.
    Type: Grant
    Filed: February 1, 1995
    Date of Patent: September 25, 2001
    Assignee: Dade Behring Marburg GmbH
    Inventors: Klaus Bosslet, Roland Kurrle, Hans Harald Sedlacek, Ernst-Jurgen Kanzy, Takako Katoh, Hans Ulrich Schorlemmer, Gerhard Luben
  • Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
    Patent number: 5849799
    Abstract: Methods are disclosed for treatment of hyperreactive inflammatory diseases of humans and animals comprising administering a pharmaceutically effective amount of deoxyspergualin to a human or an animal.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: December 15, 1998
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Jurgen Lindner, Gerhard Dickneite, Hans-Ulrich Schorlemmer, Klaus Bosslet
  • Compositions comprising lipoproteins and crotonamide derivatives
    Patent number: 5780592
    Abstract: A composition comprising lipoproteins and a compound of the formula I ##STR1## stereoisomeric form or salt thereof, suitable for the treatment of immunological disorders, cancer or in transplantation.
    Type: Grant
    Filed: December 10, 1996
    Date of Patent: July 14, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Stefan Mullner, Axel Hofmann, Karin Saar, Hans-Ulrich Schorlemmer, Robert Bartlett
  • Transglutaminases as immunosuppressants
    Patent number: 5695753
    Abstract: A description is given of the possibility of using transglutaminases in a process for the preparation of an immunosuppressant. Additionally described is a pharmaceutical containing a transglutaminase and a plasminogen activator inhibitor.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 9, 1997
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Thomas Stief, Norbert Heimburger, Hans Ulrich Schorlemmer
  • Glycosylated prodrugs, their method of preparation and their uses
    Patent number: 5561119
    Abstract: Glycosylated prodrugs, a preparation method therefor, and their use with tumor-specific immunoenzymatic conjugates for the treatment of cancer, are described. These anthracycline prodrugs have formula (I).
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: October 1, 1996
    Assignees: Laboratoires Hoechst, Behringwerke A.G.
    Inventors: Jean-Claude Jacquesy, Jean-Pierre Gesson, Claude Monneret, Martine Mondon, Brigitte Renoux, Jean-Claude Florent, Michel Koch, Fran.cedilla.ois Tillequin, Hans H. Sedlacek, Manfred Gerken, Cenek Kolar, Gilbert Gaudel, Klaus Bosslet, J org Czech, Dieter Hoffman, Gerhard Seemann, Hans-Ulrich Schorlemmer, Gerhard Dickneite
  • Use of 15-deoxyspergualine as a pharmaceutical
    Patent number: 4847299
    Abstract: The use of 15-deoxyspergualine for the preparation of a pharmaceutical for the therapy of degenerative diseases is claimed.
    Type: Grant
    Filed: July 31, 1987
    Date of Patent: July 11, 1989
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Gerhard Dickneite, Hans-Ulrich Schorlemmer, Hans P. Kraemer, Hans H. Sedlacek
  • 1,3-thiazoles and their use as immunomodulators
    Patent number: 4762848
    Abstract: Heterocyclic sulfides of the general formula heterocycle-S-R, a process for their preparation and, in particular, their use for immunostimulation, immunorestoration and cytostatic treatment, and pharmaceutical agents, which contain a sulfide of this type, for these indications.
    Type: Grant
    Filed: March 10, 1986
    Date of Patent: August 9, 1988
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Karl-Heinz Scheunemann, Walter Durckheimer, Jurgen Blumbach, Michael Limbert, Hans-Ulrich Schorlemmer, Gerhard Dickneite, Hans-Harald Sedlacek
  • Use of cephem compounds as immunomodulators
    Patent number: 4701452
    Abstract: The use of cephem compounds of the general formula I ##STR1## to increase the immunological responsiveness of mammals and formulations which contain an effective content of cephem compounds of the general formula I.
    Type: Grant
    Filed: February 15, 1985
    Date of Patent: October 20, 1987
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Michael Limbert, Walter Durckheimer, Hans-Ulrich Schorlemmer, Gerhard Dickneite
  • Use of Lycorine as an immunosuppressor
    Patent number: 4699912
    Abstract: The fact that Lycorine can be used for suppression of the immune system of mammals is described. Lycorine is therefore suitable for the therapy of autoimmune diseases, immune complex diseases and allergic and rheumatic conditions and for prophylaxis against transplant rejections.
    Type: Grant
    Filed: July 12, 1985
    Date of Patent: October 13, 1987
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Gerhard Dickneite, Hans-Ulrich Schorlemmer, Hans-Harald Sedlacek
  • Immunosuppressive chromone alkaloid
    Patent number: 4603137
    Abstract: The present invention relates to a compound of the formula ##STR1## and to a process for its isolation from plants of the family comprising the meliaceae. The compound has, in particular, immunosuppressive properties, and can therefore be used as a medicament.
    Type: Grant
    Filed: August 10, 1984
    Date of Patent: July 29, 1986
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Sujata V. Bhat, Virbala Shah, Alihussein N. Dohadwalla, Sadashiv M. Mandrekar, Noel J. de Souza, Gerhard Dickneite, Roland Kurrle, Hans-Ulrich Schorlemmer, Hans-Harald Sedlacek
  • Use of the diterpene derivative forskolin for immunostimulation
    Patent number: 4578399
    Abstract: The possibility of using the diterpene derivative forskolin (1.alpha., 6.beta., 9.alpha.-trihydroxy-7.beta.-acetoxy-8,13-epoxy-14-labden-11-one) to increase the immunological responsiveness of mammals is described.
    Type: Grant
    Filed: April 24, 1984
    Date of Patent: March 25, 1986
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Hans-Ulrich Schorlemmer, Gerhard Dickneite, Hans-Harald Sedlacek, Noel J. de Souza, Alihussein N. Dohadwalla